Table 2 Subjects absorbed dose and effective dose of 99mTc-HYNIC-PSMA.

From: Evaluation of Radiation dosimetry of 99mTc-HYNIC-PSMA and imaging in prostate cancer

Target organ

Absorbed dose (mGy/MBq)

Adrenals

2.84E-03 ± 3.78E-04

Brain

4.12E-04 ± 2.34E-04

Breasts

8.04E-04 ± 2.97E-04

Gallbladder

2.31E-03 ± 3.66E-04

Lower large intestine wall

2.60E-03 ± 3.87E-04

Small intestine wall

1.88E-03 ± 1.99E-04

Stomach wall

1.58E-03 ± 2.75E-04

Upper large intestine wall

1.71E-03 ± 2.20E-04

Heart wall

3.87E-03 ± 1.53E-03

Kidneys

2.87E-02 ± 1.53E-03

Liver

3.76E-03 ± 6.06E-04

Lungs

5.41E-03 ± 2.10E-03

Muscle

1.28E-03 ± 2.05E-04

Pancreas

2.49E-03 ± 3.16E-04

Red marrow

1.32E-03 ± 2.43E-04

Osteogenic cells

2.38E-03 ± 7.75E-04

Skin

6.00E-04 ± 1.61E-04

Spleen

6.68E-03 ± 2.20E-03

Salivary glands

1.28E-02 ± 4.25E-03

Testes

1.65E-03 ± 2.56E-04

Thymus

1.21E-03 ± 4.40E-04

Thyroid

6.20E-04 ± 3.10E-04

Urinary bladder wall

3.53E-02 ± 9.01E-03

Total body

1.54E-03 ± 2.43E-04

Effective dose (mSv/MBq)

3.72E-03 ± 4.50E-04

  1. (Data are mean ± SD; n = 5).